Annual Book Value
$131.46 M
-$105.63 M-44.55%
December 31, 2024
Summary
- As of March 13, 2025, PRLD annual book value is $131.46 million, with the most recent change of -$105.63 million (-44.55%) on December 31, 2024.
- During the last 3 years, PRLD annual book value has fallen by -$154.44 million (-54.02%).
- PRLD annual book value is now -54.02% below its all-time high of $285.90 million, reached on December 31, 2021.
Performance
PRLD Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Book Value
$131.46 M
-$24.97 M-15.96%
December 1, 2024
Summary
- As of March 13, 2025, PRLD quarterly book value is $131.46 million, with the most recent change of -$24.97 million (-15.96%) on December 1, 2024.
- Over the past year, PRLD quarterly book value has dropped by -$24.97 million (-15.96%).
- PRLD quarterly book value is now -63.13% below its all-time high of $356.57 million, reached on March 31, 2021.
Performance
PRLD Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Book Value Formula
Book Value = Total Assets − Total Liabilities
PRLD Book Value Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -44.5% | -16.0% |
| 3 y3 years | -54.0% | -32.7% |
| 5 y5 years | +366.1% | -32.7% |
PRLD Book Value Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -54.0% | at low | -54.0% | at low |
| 5 y | 5-year | -54.0% | +366.1% | -63.1% | +289.7% |
| alltime | all time | -54.0% | +366.1% | -63.1% | +289.7% |
Prelude Therapeutics Incorporated Book Value History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $131.46 M(-44.6%) | - |
| Dec 2024 | - | $131.46 M(-16.0%) |
| Sep 2024 | - | $156.43 M(-14.2%) |
| Jun 2024 | - | $182.28 M(-13.5%) |
| Mar 2024 | - | $210.73 M(-11.1%) |
| Dec 2023 | $237.09 M(+21.3%) | $237.09 M(-0.5%) |
| Sep 2023 | - | $238.26 M(-9.1%) |
| Jun 2023 | - | $262.06 M(+49.5%) |
| Mar 2023 | - | $175.30 M(-10.3%) |
| Dec 2022 | $195.44 M | $195.44 M(-10.1%) |
| Sep 2022 | - | $217.41 M(-9.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $240.84 M(-8.0%) |
| Mar 2022 | - | $261.81 M(-8.4%) |
| Dec 2021 | $285.90 M(+34.7%) | $285.90 M(-8.1%) |
| Sep 2021 | - | $311.24 M(-6.9%) |
| Jun 2021 | - | $334.36 M(-6.2%) |
| Mar 2021 | - | $356.57 M(+68.0%) |
| Dec 2020 | $212.18 M(-529.4%) | $212.18 M(-7.1%) |
| Sep 2020 | - | $228.31 M(-429.4%) |
| Jun 2020 | - | -$69.31 M(+40.3%) |
| Dec 2019 | -$49.41 M(+117.7%) | -$49.41 M |
| Dec 2018 | -$22.69 M | - |
FAQ
- What is Prelude Therapeutics Incorporated annual book value?
- What is the all time high annual book value for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated annual book value year-on-year change?
- What is Prelude Therapeutics Incorporated quarterly book value?
- What is the all time high quarterly book value for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated quarterly book value year-on-year change?
What is Prelude Therapeutics Incorporated annual book value?
The current annual book value of PRLD is $131.46 M
What is the all time high annual book value for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high annual book value is $285.90 M
What is Prelude Therapeutics Incorporated annual book value year-on-year change?
Over the past year, PRLD annual book value has changed by -$105.63 M (-44.55%)
What is Prelude Therapeutics Incorporated quarterly book value?
The current quarterly book value of PRLD is $131.46 M
What is the all time high quarterly book value for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high quarterly book value is $356.57 M
What is Prelude Therapeutics Incorporated quarterly book value year-on-year change?
Over the past year, PRLD quarterly book value has changed by -$24.97 M (-15.96%)